Search

Search Constraints

You searched for: Author/Creator Austin, Christopher P

Search Results

2. Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1–2 trial. Issue 10104 (14th October 2017)

3. Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit. (10th June 2021)

4. The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment. (17th August 2020)